1 / 35

THE PHARMACOLOGY OF ADRENERGIC RECEPTORS

THE PHARMACOLOGY OF ADRENERGIC RECEPTORS. M.T. Piascik PHA 824 December 11 & 16, 2008. Learning Objectives. The student should be able to explain or describe; The pharmacodynamic principles that aid in the understanding of adrenergic receptors and the actions of drugs on these receptors.

LeeJohn
Download Presentation

THE PHARMACOLOGY OF ADRENERGIC RECEPTORS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. THE PHARMACOLOGY OF ADRENERGIC RECEPTORS M.T. Piascik PHA 824 December 11 & 16, 2008

  2. Learning Objectives The student should be able to explain or describe; The pharmacodynamic principles that aid in the understanding of adrenergic receptors and the actions of drugs on these receptors. The criteria upon which alpha and beta receptors are defined. The second messenger systems utilized by alpha and beta receptors and how activation of these receptors leads to a change in physiologic function.

  3. Learning Objectives(cont.) The student should be able to explain or describe; The effects of alpha and beta receptor activation on the heart and blood vessels. The effects of isoproterenol, epinephrine and norepinephrine on the cardiovascular system. The clinical uses and potential toxicities of epinephrine, norepinephrine and isoproterenol with emphasis on epinephrine.

  4. The Adrenergic Receptors

  5. Beta Adrenergic Receptors DRUG KD BETA1 RECEPTORKD BETA2 RECEPTOR Epinephrine 800 nM800 nM Norepinephrine 1000 nM 10,000 nM Isoproterenol 80 nM80 nM

  6. Which of the dose-response curves represents activation of the beta1 receptor and which represents activation of the beta2 receptor?

  7. Beta Adrenergic Receptor Systems Tissue Receptor Subtype Heart beta1 Adipose tissue beta1 Vascular smooth muscle beta2 Airway smooth muscle beta2 Kidney-renin release from JG cells beta1

  8. Cellular Signaling Activated by the Beta1 Receptor in the Heart

  9. Rhythm disturbances are a major concern with drugs that activate the beta1 receptor. Physiologic Consequences of Beta1 Receptor Activation

  10. The BETA1-Adrenergic Receptor as a Therapeutic Target • Agonists- congestive heart failure 2) Antagonists- hypertension, ischemic heart disease, congestive heart failure, supraventricular tachyarrhythmias.

  11. Cellular Signaling Activated by the Beta2 Receptor in Smooth Muscle

  12. Physiologic Consequences of Beta2 Receptor Activation

  13. The Beta2-Adrenergic Receptor as a Therapeutic Target Agonists- Airways dysfunction (asthma, chronic bronchitis emphysema), tocolytics Antagonists- No therapeutic uses.

  14. The BETA2-Adrenergic Receptor as a Therapeutic Target • Agonists- congestive heart failure 2) Antagonists- hypertension, ischemic heart disease, congestive heart failure, supraventricular tachyarrhythmias.

  15. Alpha Adrenergic Receptors KD KDKD BETA1 RECEPTOR BETA1 RECEPTORALPHA RECEPTOR Epinephrine 800 nM 800 nM5000 nM Norepinephrine 1000 nM 10,000 nM* 6000 nM Isoproterenol 80 nM 80 nM 10,000 nM** * At doses used in therapeutics, Norepinephrine is void of Beta2 activity ** At doses used in therapeutics, Isoproterenol is void of Alpha1 activity

  16. Presynaptic Alpha2 Receptors

  17. Postsynaptic Alpha1 Receptors

  18. Physiologic Consequences of Alpha1 Receptor Activation

  19. Interaction Between Vascular Alpha1 and Beta2 Receptors

  20. Integrated Cardiovascular Responses

  21. Integrated Cardiovascular Response to Isoproterenol and Norepinephrine

  22. Integrated Cardiovascular Response to Epinephrine

  23. Therapeutic Uses of Epinephrine Oral dosing of epinephrine, norepinephrine or isoproterenol is not possible due to its rapid metabolism in the gut by MAO. Epinephrine can be given topically, by injection (s.c., i.m. i.v) or inhalation

  24. Therapeutic Uses of Epinephrine(cont.) Actions at the Beta2 Receptor • The treatment of respiratory distress or bronchspasm caused for example by asthma (i.e. status asthmaticus) or anaphylaxis as a result of allergic responses. Actions at the Beta1 Receptor • Epinephrine is also used to provide rapid inotropic support in cardiopulmonary resuscitation

  25. Therapeutic Uses of Epinephrine(cont.) Actions at the Beta2 Receptor • The treatment of respiratory distress or bronchspasm caused for example by asthma (i.e. status asthmaticus) or anaphylaxis as a result of allergic responses. Actions at the Beta1 Receptor • Epinephrine is also used to provide rapid inotropic support in cardiopulmonary resuscitation

  26. Therapeutic Uses of Epinephrine(cont.) Actions at the Alpha1 Receptor • Epinephrine is often used in combination with local anesthetic agents (such as articaine, bupivacaine or lidocaine) to prolong the duration of anesthetic action. • Epinephrine is used in surgery to reduce bleed.

  27. Epinephrine Toxicities • Arrhythmias • Hypertension • Toxicity can occur following systemic administration or systemic absorption following oral administration.

  28. Epinephrine Toxicities • Arrhythmias • Hypertension • Toxicity can occur following systemic administration or systemic absorption following oral administration.

  29. Epinephrine Toxicities • Toxicity can be potentiated in patients taking tricyclic antidepressants, nonselective beta blockers, cocaine and amphetamine-like drugs and those under general anesthesia.

  30. Beta1-AR Beta2-AR

More Related